Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors

Lucy Haggstrom, Yeh Chen Lee, Maria-Pilar Barretina-Ginesta, Anna Jaeger, Linn Woelber, Hannah Woopen, Madeline Rhind, Jean-Sébastien Frenel, Aanum Aanum, Katharina Bischof, Marta Mongillo, Allison L. Brodsky, Jonathan Ledermann, Talayeh S. Ghezelayagh, Ingrid Boere, Sabrina Kaiser, Constanza Maximiano, Ora Rosengarten, Tamar Safra, Ana Pertejo, Sabrina Cecere, Isabelle Ray-Coquard, Stephanie Lheureux, Ros Glasspool, Marta Gil-Martin, Laura Tookman, Se Ik Kim, Suzana Mittelstadt, Miguel Corbellas Aparicio, Isabel Palacio, Cristina Martin-Lorente, Rebecca Kristeleit, Helena de la Cueva, Nelleke Ottevanger, Maria Quindós Varela, Hiroyuki Yoshida, Theresa Link, Lydia Gaba, Gloria Marquina, Nikki Burdett, Paul Johannet, Juliane Reichenbach, Tjoung-Won Park-Simon, Philip H. Klecker, Antonio González-Martín, Christian Marth, Clemens Liebrich, Levan Dzotsenidze, Sabine Heublein, Lawrence Kasherman, Cristina Perez, Maria Masvidal, Pau Guillén Sentís, Nikolaus de Gregorio, Franziska Hemptenmacher, Felix Hilpert, Jalid Sehouli, Clare Scott, Katherine Mary Tucker, Jack Dong, Cristina Fortuno, Amanda B. Spurdle, Michael Friedlander, Unknown, Susan Ellard, Anna Tinker, Andrew Clamp, Iain McNeish, Nicoletta Colombo, Sandro Pignata, Kristina Lindemann, Patricia Roxburgh, Jae-Weon Kim, Shannon Westin, Jonathan Berek, William Tew, Carol Aghajanian, Philipp Harter

Open source

DOI
10.1001/jamaoncol.2026.1924
Published
2026-08-01
Container
JAMA Oncology
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamaoncol.2026.1924,
  title = {Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors},
  author = {Lucy Haggstrom and Yeh Chen Lee and Maria-Pilar Barretina-Ginesta and Anna Jaeger and Linn Woelber and Hannah Woopen and Madeline Rhind and Jean-Sébastien Frenel and Aanum Aanum and Katharina Bischof and Marta Mongillo and Allison L. Brodsky and Jonathan Ledermann and Talayeh S. Ghezelayagh and Ingrid Boere and Sabrina Kaiser and Constanza Maximiano and Ora Rosengarten and Tamar Safra and Ana Pertejo and Sabrina Cecere and Isabelle Ray-Coquard and Stephanie Lheureux and Ros Glasspool and Marta Gil-Martin and Laura Tookman and Se Ik Kim and Suzana Mittelstadt and Miguel Corbellas Aparicio and Isabel Palacio and Cristina Martin-Lorente and Rebecca Kristeleit and Helena de la Cueva and Nelleke Ottevanger and Maria Quindós Varela and Hiroyuki Yoshida and Theresa Link and Lydia Gaba and Gloria Marquina and Nikki Burdett and Paul Johannet and Juliane Reichenbach and Tjoung-Won Park-Simon and Philip H. Klecker and Antonio González-Martín and Christian Marth and Clemens Liebrich and Levan Dzotsenidze and Sabine Heublein and Lawrence Kasherman and Cristina Perez and Maria Masvidal and Pau Guillén Sentís and Nikolaus de Gregorio and Franziska Hemptenmacher and Felix Hilpert and Jalid Sehouli and Clare Scott and Katherine Mary Tucker and Jack Dong and Cristina Fortuno and Amanda B. Spurdle and Michael Friedlander and Unknown and Susan Ellard and Anna Tinker and Andrew Clamp and Iain McNeish and Nicoletta Colombo and Sandro Pignata and Kristina Lindemann and Patricia Roxburgh and Jae-Weon Kim and Shannon Westin and Jonathan Berek and William Tew and Carol Aghajanian and Philipp Harter},
  year = {2026},
  journal = {JAMA Oncology},
  doi = {10.1001/jamaoncol.2026.1924},
  url = {https://doi.org/10.1001/jamaoncol.2026.1924}
}

RIS

TY  - JOUR
TI  - Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors
AU  - Lucy Haggstrom
AU  - Yeh Chen Lee
AU  - Maria-Pilar Barretina-Ginesta
AU  - Anna Jaeger
AU  - Linn Woelber
AU  - Hannah Woopen
AU  - Madeline Rhind
AU  - Jean-Sébastien Frenel
AU  - Aanum Aanum
AU  - Katharina Bischof
AU  - Marta Mongillo
AU  - Allison L. Brodsky
AU  - Jonathan Ledermann
AU  - Talayeh S. Ghezelayagh
AU  - Ingrid Boere
AU  - Sabrina Kaiser
AU  - Constanza Maximiano
AU  - Ora Rosengarten
AU  - Tamar Safra
AU  - Ana Pertejo
AU  - Sabrina Cecere
AU  - Isabelle Ray-Coquard
AU  - Stephanie Lheureux
AU  - Ros Glasspool
AU  - Marta Gil-Martin
AU  - Laura Tookman
AU  - Se Ik Kim
AU  - Suzana Mittelstadt
AU  - Miguel Corbellas Aparicio
AU  - Isabel Palacio
AU  - Cristina Martin-Lorente
AU  - Rebecca Kristeleit
AU  - Helena de la Cueva
AU  - Nelleke Ottevanger
AU  - Maria Quindós Varela
AU  - Hiroyuki Yoshida
AU  - Theresa Link
AU  - Lydia Gaba
AU  - Gloria Marquina
AU  - Nikki Burdett
AU  - Paul Johannet
AU  - Juliane Reichenbach
AU  - Tjoung-Won Park-Simon
AU  - Philip H. Klecker
AU  - Antonio González-Martín
AU  - Christian Marth
AU  - Clemens Liebrich
AU  - Levan Dzotsenidze
AU  - Sabine Heublein
AU  - Lawrence Kasherman
AU  - Cristina Perez
AU  - Maria Masvidal
AU  - Pau Guillén Sentís
AU  - Nikolaus de Gregorio
AU  - Franziska Hemptenmacher
AU  - Felix Hilpert
AU  - Jalid Sehouli
AU  - Clare Scott
AU  - Katherine Mary Tucker
AU  - Jack Dong
AU  - Cristina Fortuno
AU  - Amanda B. Spurdle
AU  - Michael Friedlander
AU  - Unknown
AU  - Susan Ellard
AU  - Anna Tinker
AU  - Andrew Clamp
AU  - Iain McNeish
AU  - Nicoletta Colombo
AU  - Sandro Pignata
AU  - Kristina Lindemann
AU  - Patricia Roxburgh
AU  - Jae-Weon Kim
AU  - Shannon Westin
AU  - Jonathan Berek
AU  - William Tew
AU  - Carol Aghajanian
AU  - Philipp Harter
PY  - 2026
JO  - JAMA Oncology
DO  - 10.1001/jamaoncol.2026.1924
UR  - https://doi.org/10.1001/jamaoncol.2026.1924
ER  - 

APA

Haggstrom, L., Lee, Y. C., Barretina-Ginesta, M., Jaeger, A., Woelber, L., Woopen, H., Rhind, M., Frenel, J., Aanum, A., Bischof, K., Mongillo, M., Brodsky, A. L., Ledermann, J., Ghezelayagh, T. S., Boere, I., Kaiser, S., Maximiano, C., Rosengarten, O., Safra, T., Pertejo, A., Cecere, S., Ray-Coquard, I., Lheureux, S., Glasspool, R., Gil-Martin, M., Tookman, L., Kim, S. I., Mittelstadt, S., Aparicio, M. C., Palacio, I., Martin-Lorente, C., Kristeleit, R., Cueva, H. D. L., Ottevanger, N., Varela, M. Q., Yoshida, H., Link, T., Gaba, L., Marquina, G., Burdett, N., Johannet, P., Reichenbach, J., Park-Simon, T., Klecker, P. H., González-Martín, A., Marth, C., Liebrich, C., Dzotsenidze, L., Heublein, S., Kasherman, L., Perez, C., Masvidal, M., Sentís, P. G., Gregorio, N. D., Hemptenmacher, F., Hilpert, F., Sehouli, J., Scott, C., Tucker, K. M., Dong, J., Fortuno, C., Spurdle, A. B., Friedlander, M., Unknown, Ellard, S., Tinker, A., Clamp, A., McNeish, I., Colombo, N., Pignata, S., Lindemann, K., Roxburgh, P., Kim, J., Westin, S., Berek, J., Tew, W., Aghajanian, C., & Harter, P. (2026). Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2026.1924

Source records